Company news

Hepion Pharmaceuticals, Inc. news in 2026

Hepion Pharmaceuticals, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Hepion Pharmaceuticals Receives Positive FDA Response on GV104 in Gambling Disorder, a Condition With No Approved Medication

October 19, 2026

Hepion Pharmaceuticals Completes Acquisition of Gravitas Life Sciences and Provides Corporate Update

October 14, 2026